Search results
Sapien valve performs equally well for small and large aortic annuli, Edwards finds
MedTech Dive via Yahoo Finance· 4 days agoThe analysis adds to a debate about the effectiveness of Edwards versus Medtronic TAVR devices in...
Council Post: Nurturing Remote Talent: 19 Tips For First-Time Managers
Forbes· 14 hours agoAs hybrid and remote work environments have become more common in recent years, it has challenged...
BTS’ RM Notches His Fifth Solo No. 1 Hit In America
Forbes· 2 days agoRM rules several Billboard charts this week, as his new full-length Right Place, Wrong Person and the tunes featured on his latest solo collection debut....
Edwards Life Sciences sees positive results from TAVR trial
Medical Device Network via Yahoo Finance· 4 days agoEdwards says that the five-year follow-up of more than 1,300 low and intermediate-risk SAPIEN 3...
Edwards rebuffs Medtronic annulus study with 5-year TAVR safety data focused on women
FierceBiotech· 4 days agoEdwards’ analysis pulled together more than 1,350 patients from two of its PARTNER trials who...
Can Mitral Valve Innovators Dig Themselves Out of a Rut?
MedPage Today· 5 days agoWith lots of devices in development -- including transseptal devices Sapien M3, HighLife Valve,...
Next Cryptocurrency To Explode Sunday, June 9 — GameStop, Biconomy, Tron, Monero
Inside Bitcoins· 1 day agoThe altcoin market looks bullish as some coins try to bounce back. Institutional investors are now...
Fresh Monkey Fiction Pays Tribute to Palitoy Action Force Figures
SuperHeroHype via Yahoo News· 6 days agoUse included “Robo-Sapien” parts to turn the Baron Zemo-ish Wolfsbane into a spitting image of...
Primavera Sound Barcelona 2024 Was the Perfect Live Summer Playlist
Teen Vogue via Yahoo News· 7 days agoOnly five out of the 11 current members of Balming Tiger made their way to Barcelona for the...
Edwards Lifesciences Co. (NYSE:EW) Shares Acquired by Tower Research Capital LLC TRC
ETF DAILY NEWS· 3 days agoTower Research Capital LLC TRC boosted its holdings in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 62.9% during the 4th quarter, according to its most recent 13F filing with ...